Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lene Ryom

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohortWin Min Han, Lene Ryom, Caroline A Sabin, et al.
BMJ Open|March 14, 2012
Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trialJens-Ulrik Stæhr Jensen, Lars Hein, Bettina Lundgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort SettingLauren Greenberg, Lene Ryom, Gilles Wandeler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
AIDS (London, England)|August 24, 2022
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIVNadine Jaschinski, Lauren Greenberg, Bastian Neesgaard, et al.
The Lancet. HIV|June 10, 2022
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortiumBastian Neesgaard, Lauren Greenberg, Jose M Miró, et al.
Plos One|December 31, 2020
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortiumBastian Neesgaard, Amanda Mocroft, Robert Zangerle, et al.
Open Forum Infectious Diseases|February 24, 2022
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort SettingLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort CollaborationErich Tusch, Lene Ryom, Annegret Pelchen-Matthews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohortWin Min Han, Lene Ryom, Caroline A Sabin, et al.
BMJ Open|March 14, 2012
Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trialJens-Ulrik Stæhr Jensen, Lars Hein, Bettina Lundgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort SettingLauren Greenberg, Lene Ryom, Gilles Wandeler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
AIDS (London, England)|August 24, 2022
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIVNadine Jaschinski, Lauren Greenberg, Bastian Neesgaard, et al.
The Lancet. HIV|June 10, 2022
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortiumBastian Neesgaard, Lauren Greenberg, Jose M Miró, et al.
Plos One|December 31, 2020
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortiumBastian Neesgaard, Amanda Mocroft, Robert Zangerle, et al.
Open Forum Infectious Diseases|February 24, 2022
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort SettingLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort CollaborationErich Tusch, Lene Ryom, Annegret Pelchen-Matthews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Pageof 11